Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer

References

• Chu D, Wu J, Wang K, et al. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. Bmc Cancer. 2018;18:438. doi:10.1186/s12885-018-4334-5
   PubMed Web of Science ®Google Scholar
• Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387:1094–1108. doi:10.1016/S0140-6736(15)00130-0
   PubMed Web of Science ®Google Scholar
• Lee YC, Lheureux S, Oza AM. Treatment strategies for endometrial cancer: current practice and perspective. Curr Opin Obstet Gynecol. 2017;29:47–58. doi:10.1097/GCO.0000000000000338
   PubMed Web of Science ®Google Scholar
• Ramon LA, Braza-Boils A, Gilabert J, et al. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer. Hum Reprod. 2012;27:3036–3045. doi:10.1093/humrep/des292
   PubMed Web of Science ®Google Scholar
• Yan R, Yang T, Zhai H, Zhou Z, Gao L, Li Y. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF (V600E) mutation in papillary thyroid cancer cells. J Cell Biochem. 2018;119:8763–8772. doi:10.1002/jcb.27108
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang T, Wang Q, Gao H. Overexpression of microRNA-34a attenuates proliferation and induces apoptosis in pituitary adenoma cells via SOX7. Mol Ther Oncolytics. 2018;10:40–47. doi:10.1016/j.omto.2018.07.001
   PubMed Web of Science ®Google Scholar
• Li P, Xie XB, Chen Q, et al. MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-gamma. Asian Pac J Cancer Prev. 2014;15:6949–6954. doi:10.7314/apjcp.2014.15.16.6949
   PubMedGoogle Scholar
• Xiao R, Li C, Chai B. miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1. Biomed Pharmacother. 2015;74:138–144. doi:10.1016/j.biopha.2015.08.006
   PubMed Web of Science ®Google Scholar
• Dotto GP, Karine L. miR-34a/SIRT6 in squamous differentiation and cancer. Cell Cycle. 2014;13:1055–1056. doi:10.4161/cc.28378
   PubMed Web of Science ®Google Scholar
• Si W, Shen J, Du C, et al. A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance. Cell Death Differ. 2018;25:406–420. doi:10.1038/cdd.2017.176
   PubMed Web of Science ®Google Scholar
• Carreras-Badosa G, Bonmati A, Ortega FJ, et al. Altered circulating miRNA expression profile in pregestational and gestational obesity. J Clin Endocrinol Metab. 2015;100:E1446–E1456. doi:10.1210/jc.2015-2872
   PubMed Web of Science ®Google Scholar
• Ohlsson TE, Van der Hoek KH, Van der Hoek MB, et al. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol. 2009;23:265–275. doi:10.1210/me.2008-0387
   PubMedGoogle Scholar
• Sonkoly E, Pivarcsi A. microRNAs in inflammation. Int Rev Immunol. 2009;28:535–561. doi:10.3109/08830180903208303
   PubMed Web of Science ®Google Scholar
• Joladarashi D, Thandavarayan RA, Babu SS, Krishnamurthy P. Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration. Int J Mol Sci. 2014;15:15891–15911. doi:10.3390/ijms150915891
   PubMed Web of Science ®Google Scholar
• Ramon LA, Braza-Boils A, Gilabert-Estelles J, et al. microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod. 2011;26:1082–1090. doi:10.1093/humrep/der025
   PubMed Web of Science ®Google Scholar
• Gilabert-Estelles J, Braza-Boils A, Ramon LA, et al. Role of microRNAs in gynecological pathology. Curr Med Chem. 2012;19:2406–2413. doi:10.2174/092986712800269362
   PubMed Web of Science ®Google Scholar
• Cohn DE, Fabbri M, Valeri N, et al. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol. 2010;202:651–656. doi:10.1016/j.ajog.2010.02.051
   Web of Science ®Google Scholar
• Zhang W, Chen JH, Shan T, et al. miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation. Lab Invest. 2018;98:1397–1407. doi:10.1038/s41374-018-0092-x
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Zhang Z. Semi-parametric regression model for survival data: graphical visualization with R. Ann Transl Med. 2016;4:461. doi:10.21037/atm.2016.08.61
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3–14. doi:10.1016/j.addr.2015.05.001
   PubMed Web of Science ®Google Scholar
• Lu Z, Nian Z, Jingjing Z, Tao L, Quan L. MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinoma. Oncotarget. 2017;8:114281–114291. doi:10.18632/oncotarget.23218
   PubMedGoogle Scholar
• Xiong H, Li Q, Liu S, et al. Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma. PLoS One. 2014;9:e110163. doi:10.1371/journal.pone.0110163
   PubMed Web of Science ®Google Scholar
• Jurcevic S, Olsson B, Klinga-Levan K. MicroRNA expression in human endometrial adenocarcinoma. Cancer Cell Int. 2014;14:88. doi:10.1186/s12935-014-0088-6
   PubMed Web of Science ®Google Scholar
• Devor EJ, Cha E, Warrier A, Miller MD, Gonzalez-Bosquet J, Leslie KK. The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes. Onco Targets Ther. 2018;11:7205–7211. doi:10.2147/OTT.S180921
   PubMed Web of Science ®Google Scholar
• Tochigi H, Kajihara T, Mizuno Y, et al. Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017;7:40001. doi:10.1038/srep40001
   PubMedGoogle Scholar
• Hiroki E, Akahira J, Suzuki F, et al. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci. 2010;101:241–249. doi:10.1111/j.1349-7006.2009.01385.x
   PubMed Web of Science ®Google Scholar
• Myatt SS, Wang J, Monteiro LJ, et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 2010;70:367–377. doi:10.1158/0008-5472.CAN-09-1891
   PubMed Web of Science ®Google Scholar
• Chung TK, Lau TS, Cheung TH, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer. 2012;130:1036–1045. doi:10.1002/ijc.26060
   PubMed Web of Science ®Google Scholar
• Lee JW, Park YA, Choi JJ, et al. The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol. 2011;120:56–62. doi:10.1016/j.ygyno.2010.09.022
   PubMed Web of Science ®Google Scholar
• Li L, Shou H, Wang Q, Liu S. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma. Gene. 2019;694:76–82. doi:10.1016/j.gene.2018.12.076
   PubMed Web of Science ®Google Scholar
• Encarnacion-Medina J, Ortiz C, Vergne R, Padilla L, Matta J. MicroRNA expression changes in women with breast cancer stratified by DNA repair capacity levels. J Oncol. 2019;2019:7820275. doi:10.1155/2019/7820275
   PubMed Web of Science ®Google Scholar
• Wu Z, Wang H, Fang S, Xu C. MiR-449c inhibits gastric carcinoma growth. Life Sci. 2015;137:14–19. doi:10.1016/j.lfs.2015.06.020
   PubMed Web of Science ®Google Scholar
• Fonseca-Sanchez MA, Perez-Plasencia C, Fernandez-Retana J, et al. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. Oncol Rep. 2013;30:2399–2410. doi:10.3892/or.2013.2691
   PubMed Web of Science ®Google Scholar
• Hong Y, Liang H, Uzair-Ur-Rehman, et al. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer. Sci Rep. 2016;6:37421. doi:10.1038/srep37421
   PubMed Web of Science ®Google Scholar
• Yu PF, Wang Y, Lv W, et al. LncRNA NEAT1/miR-1224/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer. Eur Rev Med Pharmacol Sci. 2019;23:8403–8410. doi:10.26355/eurrev_201910_19151
   PubMed Web of Science ®Google Scholar
• Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19:1–11. doi:10.1128/mcb.19.1.1
   PubMed Web of Science ®Google Scholar
• Geisler JP, Geisler HE, Manahan KJ, et al. Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival. Int J Gynecol Cancer. 2004;14:133–137. doi:10.1111/j.1048-891x.2004.14027.x
   PubMed Web of Science ®Google Scholar
• Subramaniam KS, Omar IS, Kwong SC, et al. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. Am J Cancer Res. 2016;6:200–213.
   PubMed Web of Science ®Google Scholar
• Qiu MT, Fan Q, Zhu Z, et al. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget. 2015;6:31702–31720. doi:10.18632/oncotarget.5165
   PubMedGoogle Scholar
• Bai JX, Yan B, Zhao ZN, et al. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. Endocrinology. 2013;154:635–645. doi:10.1210/en.2012-1607
   PubMed Web of Science ®Google Scholar
• Oki S, Sone K, Oda K, et al. Oncogenic histone methyltransferase EZH2: a novel prognostic marker with therapeutic potential in endometrial cancer. Oncotarget. 2017;8:40402–40411. doi:10.18632/oncotarget.16316
   PubMedGoogle Scholar
• Huo X, Sun H, Cao D, et al. Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data. Sci Rep. 2019;9:9924. doi:10.1038/s41598-019-46195-8
   PubMed Web of Science ®Google Scholar
• Mullany LE, Herrick JS, Wolff RK, Stevens JR, Samowitz W, Slattery ML. MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases. Genes Chromosomes Cancer. 2018;57:192–202. doi:10.1002/gcc.22520
   PubMed Web of Science ®Google Scholar
• Mullany LE, Herrick JS, Wolff RK, Stevens JR, Samowitz W, Slattery ML. Transcription factor-microRNA associations and their impact on colorectal cancer survival. Mol Carcinog. 2017;56:2512–2526. doi:10.1002/mc.22698
   PubMed Web of Science ®Google Scholar
• Lania L, Majello B, De Luca P. Transcriptional regulation by the Sp family proteins. Int J Biochem Cell Biol. 1997;29:1313–1323. doi:10.1016/s1357-2725(97)00094-0
   PubMed Web of Science ®Google Scholar
• Yu JH, Schwartzbauer G, Kazlman A, Menon RK. Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression. J Biol Chem. 1999;274:34327–34336. doi:10.1074/jbc.274.48.34327
   PubMed Web of Science ®Google Scholar
• Suske G. The Sp-family of transcription factors. Gene. 1999;238:291–300. doi:10.1016/s0378-1119(99)00357-1
   PubMed Web of Science ®Google Scholar
• Maor S, Mayer D, Yarden RI, et al. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J Endocrinol. 2006;191:605–612. doi:10.1677/joe.1.07016
   PubMed Web of Science ®Google Scholar
• Tong Y, Tan Y, Zhou C, Melmed S. Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene. 2007;26:5596–5605. doi:10.1038/sj.onc.1210339
   PubMed Web of Science ®Google Scholar
• Hu J, Shan Z, Hu K, et al. miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1. Int J Oncol. 2016;49(1):325–335. doi:10.3892/ijo.2016.3533
   PubMed Web of Science ®Google Scholar
• Qin F, Zhao Y, Shang W, et al. Sinomenine relieves oxygen and glucose deprivation-induced microglial activation via inhibition of the SP1/miRNA-183-5p/IkappaB-alpha signaling pathway. Cell Mol Biol (Noisy-Le-Grand). 2018;64:140–147. doi:10.14715/cmb/2018.64.10.23
   PubMed Web of Science ®Google Scholar
• Shao W, Li Y, Chen F, Jia H, Jia J, Fu Y. Long non-coding RNA DLEU1 contributes to the development of endometrial cancer by sponging miR-490 to regulate SP1 expression. Pharmazie. 2018;73:379–385. doi:10.1691/ph.2018.8352
   PubMed Web of Science ®Google Scholar
• Chia NY, Deng N, Das K, et al. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development. Gut. 2015;64:707–719. doi:10.1136/gutjnl-2013-306596
   PubMed Web of Science ®Google Scholar
• Pei Y, Yao Q, Yuan S, et al. GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3. Oncotarget. 2016;7:77890–77901. doi:10.18632/oncotarget.12839
   PubMedGoogle Scholar
• Han X, Tang J, Chen T, Ren G. Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF-kappaB signaling. J Cell Biochem. 2019;120:917–927. doi:10.1002/jcb.27455
   PubMed Web of Science ®Google Scholar
• Chmelarova M, Kos S, Dvorakova E, et al. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium. Clin Chem Lab Med. 2014;52:1229–1234. doi:10.1515/cclm-2013-0162
   PubMed Web of Science ®Google Scholar
• Sanchez-Vega B, Gandhi V. Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1). Br J Haematol. 2009;144:856–864. doi:10.1111/j.1365-2141.2008.07549.x
   PubMed Web of Science ®Google Scholar
• Ahlquist T, Lind GE, Costa VL, et al. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer. 2008;7(1):94. doi:10.1186/1476-4598-7-94
   PubMedGoogle Scholar
• Lind GE, Kleivi K, Meling GI, et al. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol. 2006;28:259–272. doi:10.1155/2006/949506
   PubMed Web of Science ®Google Scholar
• Chang W, Ma L, Lin L, et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer. 2009;125:2844–2853. doi:10.1002/ijc.24699
   PubMed Web of Science ®Google Scholar
• Gu Y, Deng B, Kong J, et al. Functional polymorphisms in NR3C1 are associated with gastric cancer risk in Chinese population. Oncotarget. 2017;8:105312–105319. doi:10.18632/oncotarget.22172
   PubMedGoogle Scholar
• Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53–65. doi:10.1016/j.cca.2013.05.002
   PubMed Web of Science ®Google Scholar
• Ihira K, Dong P, Xiong Y, et al. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis. Oncotarget. 2017;8:13509–13520. doi:10.18632/oncotarget.14586
   PubMedGoogle Scholar
• Di Tucci C, Capone C, Galati G, et al. Immunotherapy in endometrial cancer: new scenarios on the horizon. J Gynecol Oncol. 2019;30:e46. doi:10.3802/jgo.2019.30.e46
   PubMed Web of Science ®Google Scholar
• Teng MW, Ngiow SF, Ribas A, Smyth MJ. Classifying Cancers Based on T-cell Infiltration and PD-L1. Cancer Res. 2015;75:2139–2145. doi:10.1158/0008-5472.CAN-15-0255
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321–330. doi:10.1038/nature21349
   PubMed Web of Science ®Google Scholar
• Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–296. doi:10.1016/j.cell.2004.07.013
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Allavena P, Garlanda C, Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol. 2009;70:325–330. doi:10.1016/j.humimm.2009.02.008
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329–360. doi:10.1146/annurev.immunol.22.012703.104803
   PubMed Web of Science ®Google Scholar